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The porcine lymphotropic herpesvirus 1 (PLHV-1), the first gammaherpesvirus of pigs, has been detected at a high
prevalence in healthy pig populations. A porcine gammaherpesvirus has also been detected at high copy numbers in animals
suffering from posttransplant lymphoproliferative disease (PTLD). While human PTLD is a EBV-associated complication
following clinical transplantation, porcine PTLD is a disease recently described in pigs undergoing experimental allogeneic
hematopoietic stem cell transplantation. Here we demonstrate that PLHV-1 and the virus present in porcine PTLD are
indistinguishable, and present the characterization of 73 kbp of the genome of PLHV-1. We identified homologs of cellular
genes, including a putative G protein-coupled receptor (GCR) as well as a viral homolog of the bcl-2 oncogene (v-bcl-2) and
show significant transcription of these genes as well as of several other PLHV-1 genes in lymph nodes of a PTLD-affected
pig. These data indicate that PLHV-1 is active during PTLD and may be involved in the etiology of this lymphoproliferativeINTRODUCTION
Human herpesviruses cause morbidity and mortality in
patients who receive allotransplants. Disease can be
induced either by reactivation of latent virus in the recip-
ient or through transmission of the herpesvirus from
donor-derived cells or organs (Tolkoff-Rubin and Rubin,
1998). Similarly, during xenotransplantation, it is possible
that animal herpesviruses might be transferred to a re-
cipient and possibly cause disease (Chapman et al.,
1995). Xenotransplantation research is focused on the
use of pigs as donors of organs for human transplanta-
tion. Therefore, attempts are presently made to breed
pathogen-free pigs for xenotransplantation. For this pur-
pose, valid monitoring methods as well as comprehen-
sive knowledge of porcine microorganisms is needed
(Gu¨nzburg and Solmons, 2000).
A search for unknown porcine herpesviruses recently
identified two novel gammaherpesviruses of pigs (por-
cine lymphotropic herpesviruses 1 and 2 [PLHV-1 and
PLHV-2]). These viruses are widely distributed with high
prevalence among domestic and feral pigs (Ehlers et al.,
1999; Ulrich et al., 1999). Nucleotide sequence analysis
of the DNA polymerase (DPOL) genes of the PLHVs
1 To whom correspondence and reprint requests should be ad-383indicated that both viruses are closely related to the
alcelaphine herpesvirus 1 (AIHV-1), a herpesvirus of ru-
minants and the causative agent of fatal malignant ca-
tarrhal fever (MCF) in cattle (Ulrich et al., 1999). Although
no disease is currently attributable to PLHV infection in
pigs under natural conditions, a porcine gammaherpes-
virus was recently reported to be associated with exper-
imental posttransplant lymphoproliferative disease
(PTLD) in miniature swine following allogeneic hemato-
poietic stem cell transplantation (Huang et al., 2001). The
porcine PTLD syndrome reported by Huang et al. closely
resembles human PTLD. In particular, both syndromes
involve B cell lymphoproliferation and high mortality. Fur-
thermore, while the human PTLD is strongly linked to the
presence of Epstein-Barr virus (EBV) (Paya et al., 1999;
Ferry and Harris, 1994), markedly elevated levels of a
gammaherpesvirus have been observed with the porcine
PTLD. Because of the above similarities, PTLD in minia-
ture swine has been discussed as a large animal model
for human PTLD (Huang et al., 2001).
To investigate the molecular mechanisms by which
EBV and PLHV might be involved in the production of
PTLD, it is necessary to know the genes that both viruses
possess. While EBV has been completely sequenced,
data for PLHV have been limited to the DPOL and gly-
coprotein B (gB) genes. In this study we isolated 73 kbpdisease. © 2002 Elsevier Science (USA)
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of novel PLHV-1 genomic DNA which encompasses
open reading frames (ORF) 03 to 52 as well as flanking
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sequences. Furthermore, we demonstrate that PLHV-1
and the PTLD-associated porcine herpesvirus are indis-
tinguishable and are transcribed in PTLD-affected pigs.
RESULTS
Determination of novel PLHV-1 sequences
Novel PLHV-1 sequences were obtained by PCR-
based genome walking from the splenic DNA of a do-
mestic pig which was PCR-positive for PLHV-1 but PCR-
negative for PLHV-2 (Ulrich et al., 1999). The genome
walking approach was chosen because neither a lytical
cell culture system nor a permanent cell line harboring
latent PLHV-1 is available, limiting experimental work on
PLHV-1 to primary organ and tissue materials (Ehlers et
al., 1999; Ulrich et al., 1999). The PCR products were
sequenced at both ends and verified by BLAST analysis.
To confirm the organization of the PCR fragments, new
overlapping PCRs were designed using the initial se-
quence data and the confirmatory products were se-
quenced in both orientations. When sequencing pro-
gressed into nonconserved regions, BLAST verification
of the deduced sequences was not possible. Genomic
DNAs derived from pigs free of PLHV were used as
negative control templates in such cases to ensure the
viral origin of the sequences. Using this approach,
73.200 bp of PLHV-1 genomic DNA sequence was ob-
tained and its contiguity demonstrated by performing
seven overlapping long-distance-PCRs which generated
amplicons of 10.8–13.4 kbp in length (Fig. 1a and c). The
overall GC content (37.9%) and the CpG dinucleotide
frequency (ratio observed/expected 0.38) of the 73 kbp
were found to be very low.
Coding capacity and gene arrangement of PLHV-1
The conserved genes of gammaherpesviruses are ar-
ranged in a common block organization (Simas and Ef-
stathiou, 1998; Schultz, 1998). The 73 kbp region of
PLHV-1 presented here comprises ORFs 03 to 52 and
therefore includes the entire first and second conserved
gene block of this herpesvirus subfamily and the begin-
ning of the third (Fig. 1, Table 1).
Within the first conserved gene block, ORFs for a viral
FGAM-synthetase (ORF 03), major DNA binding protein
(ORF 06), transport protein (ORF 07), glycoprotein B (gB;
ORF 08), DNA polymerase (ORF 09), and two conserved
ORFs with unknown function (ORF 10 and 11) were iden-
tified. In addition, two ORFs not conserved among the
gammaherpesviruses, E4/BALF1h and A5/BILF1h, were
also identified (Fig. 1). Within the second conserved
gene block (ORFs 17–50), genes encoding a thymidine
kinase (TK, ORF 21), glycoprotein H (gH, ORF 22), major
capsid protein (MCP, ORF 25), terminase (ORFs 29a,b),
glycoprotein M (gM, ORF 39), helicase (ORF44), and
glycoprotein L (gL, ORF 47) genes as well as two imme-
diate early genes (ORFs 45 and 50a,b) were identified.
Within the third conserved gene block, ORF 52 and the
partial sequence of ORF53 were identified. Between the
second and the third conserved gene block, three non-
conserved ORFs were identified and designated A6/
BZLF1h, A7/BZLF2h, and A8/BLLF1h. Outside the con-
served gene blocks, eight unique ORFs were identified
which showed no significant homologies to known her-
pesvirus genes.
Homology and possible function of nonconserved
PLHV-1 genes
Structural homologs of PLHV-1 FGAM-synthetase
(ORF 03) are found at the same position in alcelaphine
herpesvirus 1 (AIHV-1), equine herpesvirus 2 (EHV-2),
herpesvirus saimiri (HVS), and herpesvirus ateles (HVA).
There is also considerable homology of PLHV ORF 03 to
the ORF 75, which is located at the right-hand ends of
several rhadinovirus genomes, including AIHV-1, EHV-2,
and Kaposi sarcoma herpesvirus (KSHV) and the left end
of the EBV genome (ORF BNRF1).
The E4/BALF1h gene which was identified in PLHV-1
has no counterpart in AIHV-1, but homologs are present
in EHV-2 and EBV (genes E4 and BALF1, respectively).
BALF1 was reported to be a viral homolog (v-bcl-2) of the
mammalian bcl-2 oncogene encoding for a functional
apoptosis inhibitor (Marshall et al., 1999). Amino acid
alignments revealed a uniform distribution of homology
of PLHV-1 E4/BALF1h to human bcl-2, EBV BALF1, BHRF1,
and EHV-2 E4. The homology of E4/BALF1h is not signif-
icantly higher to the BH domains of BALF1 or the other
proteins (data not shown). Interestingly, like EBV BALF1
and EHV-2 E4, the predicted v-bcl-2 protein of PLHV-1
lacks a putative transmembrane domain at the C termi-
nus which is in contrast to the human and other gam-
maherpesvirus bcl-2 genes (Marshall et al., 1999; Bel-
lows et al., 2000).
The PLHV ORF A5/BILF1h is related to ORF A5 of
AIHV-1, ORF E6 of EHV-2 and ORF BILF1 of EBV. The
A5/BILF1 homologs all encode for proteins with seven
hydrophobic domains which show weak homology to the
ORF 74 gene products of KSHV and other gammaherpes-
viruses. In KSHV, the ORF 74 gene product was deter-
mined to represent a functional CXC chemokine receptor
with homology to the human IL-8R (Arvanitakis et al.,
1997; Rosenkilde et al., 1999).
The PLHV ORF A6/BZLF1h shows only very low homol-
ogies to the positional counterparts of AIHV-1 (ORF A6),
EBV (ORF BZLF1), and HHV-8/KSHV (ORF K8) (Lin et al.,
1999). PLHV ORF A7/BZLF2h was most closely related to
ORF A7 of AIHV-1 and ORF BZLF2 of EBV. The BZLF2
ORF was reported to encode a glycoprotein which is
required for the entry of EBV into B cells via HLA-DR
(Spriggs et al., 1996). PLHV ORF A8/BLLF1h is most
closely related to ORF A8 of AIHV-1 and ORF BLLF1
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(gp350/220) of EBV. BLLF1 has been reported to mediate
attachment of EBV to B cells via the CD21/CR2 receptor
(Tanner et al., 1987) and to induce T cell apoptosis
(Tanner and Alfieri et al., 1999).
PLHV-1 is closely related to AIHV-1 and other
ruminant gammaherpesviruses
At the amino acid level, almost all PLHV-1 genes are
closely related to those of the Gammaherpesvirinae, in
particular AIHV-1 (Table 1). Phylogenetic analysis of con-
catenated amino acid sequences of the conserved ORFs
06, 08, 09, 29, and 44 (4015aa) placed PLHV-1 close to
AIHV-1 (Fig. 2a). This was also observed in parsimonial
analysis (program Protpars) and in analyses of individual
proteins with both algorithms (data not shown). In addi-
tion, phylogenetic analysis of concatenated DPOL and
gB sequences only (360aa), in which partial gB and
DPOL sequences of additional gammaherpesviruses
(Chmielewicz et al., 2001) were included, revealed
PLHV-1 as similarly close to AIHV-1, ovine herpesvirus 2
FIG. 1. Map of the open reading frames of the 73-kbp genome stretch of PLHV-1. (a) ORFs are shown as arrows. Description of ORFs and
abbreviations are given in Table 1. Black arrows indicate ORFs found in two or all three subfamilies of the herpesviruses. Open arrows symbolize ORFs
described only for gammaherpesviruses and grey arrows symbolize ORFs specific for PLHV-1. Black lines designated A to G symbolize the genome
stretches covered by each of the seven long-distance PCRs. A scale in kbp is given above the genome. Base 1 is the first base of the genome stretch
so far determined by genome walking. This position is not identical with the beginning of the long unique region (LUR) of PLHV-1, which has not yet
been determined. (b) Magnification of the ORF 50-ORF A6 region. The results of the cDNA analysis for the spliced ORFs 50 and A6 are shown by black
lines above the ORFs. Primer pairs 988 and 1478 are indicated as arrowheads. (c) Gel electrophoresis of the long-distance PCR fragments A–G as
depicted schematically in part “a” of this figure. Second-round PCR products were loaded on a 0.7% agarose gel in 2 TBE. /BstEII or /HindIII DNA
was used as molecular markers as indicated. The cohesive ends of the /BstEII marker were not completely separated in order to achieve an
additional band of 14.140 bp.
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TABLE 1
Potential PLHV-1 ORFs and Homologs to AIHV-1, EBV, and HVS
PLHV-1 AIHV-1 EBV HHV-8/KSHV
DescriptionORF Pol. Size (aa) % id ORF % id ORF % id ORF
3  1378 32.1 3 — — — — Tegument protein. v-FGAM-synthase
E4/BALF1  178 — — 20.1 BALF1 — — v-bcl-2
6  1126 56.7 6 43.2 BALF2 47.4 6 Major DNA binding protein (MDBP)
7  675 49.1 7 37.9 BALF3 43.1 7 Transport protein
8  876 56.3 8 45.6 BALF4 46.7 8 Glycoprotein B (gB)
9  1004 63.3 9 55.3 BALF5 57.5 9 DNA polymerase (DPOL)
A5/BILF1  325 31.1 A5 24.3 BILF1 — — G-protein coupled receptor (v-GCR)
10  401 28.5 10 25.0 RAJILF1 § 10
11  409 41.9 11 29.3 RAJILF2 24.5 11
17  500 46.9 17 37.0 BVRF2 40.8 17 Capsid protein
18  261 44.4 18 30.7 BVRF1.5 40.7 18
19  549 50.9 19 36.6 BVRF1 44.1 19 Tegument protein
20  275 39.2 20 31.7 BXRF1 40.9 20
21  580 40.4 21 35.8 BXLF1 29.1 21 Thymidine kinase (TK)
22  778 38.4 22 32.2 BXLF2 27.1 22 Glycoprotein H (gH)
23  398 42.0 23 34.4 BTRF1 33.3 23
24  736 51.4 24 41.0 BcRF1 42.2 24
25  1372 67.9 25 55.9 BcLF1 56.7 25 Major capsid protein (MCP)
26  304 60.9 26 50.2 BDLF1 48.7 26 Capsid protein
27  294 39.6 27 22.1 BDLF2 30.1 27
29  683 62.5 29 52.4 BDRF1 54.1 29 Cleavage and/or packaging protein
29b *379 29b (BDRF1) 29b Cleavage and/or packaging protein. Exon II
30  79 35.4 30 20.3 BDLF3.5 26.8 30
31  206 44.8 31 34.2 BDLF4 40.2 31
32  453 33.3 32 24.3 BGLF1 26.7 32 Viral DNA cleavage/packaging protein
33  339 42.1 33 45.6 BGLF2 32.7 33
29a *304 29a (BGRF1) 29a Cleavage/packaging protein. Exon I
34  326 46.6 34 33.3 BGLF3 37.0 34
35  151 34.2 35 28.2 BGLF3.5 26.5 35
36  453 42.1 36 30.9 BGLF4 26.3 36 Kinase (PK)
37  485 61.6 37 45.3 BGLF5 42.3 37 Alkaline exonuclease
38  63 44.8 38 33.3 BBLF1 34.5 38
39  378 61.7 39 48.4 BBRF3 43.1 39 Glycoprotein M (gM)
40  455 30.6 40 24.2 BBLF2 24.2 40 Helicase–primase complex component
41  162 24.7 41 23.5 BBLF3 23.4 41 Helicase–primase complex component
42  266 45.5 42 35.8 BBRF2 36.5 42
43  567 62.3 43 50.7 BBRF1 53.6 43 Capsid protein
44  782 63.9 44 51.4 BBLF4 54.6 44 Helicase
45  223 32.3 45 29.4 BKRF4 27.4 45
46  251 65.3 46 55.6 BKRF3 53.8 46 Uracil–DNA–glycosidase
47  142 33.6 47 26.7 BKRF2 27.5 47 Glycoprotein L (gL)
48  498 29.6 48 § BRRF2 20.1 48
49  309 — — 23.0 BRRF1 22.9 49
50  *510 33.4 50 20.8 BRLF1 24.1 50 R transactivator homologue
50a *14 50a — 50a R transactivator homologue. exon I
50b 496 50b — 50b R transactivator homologue. exon II
A6/BZLF1  172 22.8 A6 § BZLF1 § K8 Zta (ZEBRA) transcription factor in EBV
A6/BZLF1a 101 — BZLF1a K8a Exon I
A6/BZLF1b 35 — BZLF1b K8b Exon II
A6/BZLF1c 36 — BZLF1c K8c Exon III
A7/BZLF2  234 31.2 A7 28.0 BZLF2 — — gp 42 in EBV (B cell fusion)
A8/BLLF1  725 23.0 A8 21.9 BLLF1 — — gp350/220 in EBV (B cell attachment)
51  115 — — — — — —
52  136 36.9 52 29.0 BLRF2 28.0 52
Note. Pol., polarity; ORF, orientation; % id, percent identity to the corresponding PLHV-1 ORF; *, splice sites experimentally confirmed; §, identity
values below 20%.
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(OvHV-2), bovine lymphotropic herpesvirus (BLHV), and
caprine herpesvirus 2 (CprHV-2). These five viruses form
a separate clade as shown in Fig. 2b.
PLHV-1 is associated with PTLD in pigs and is
genetically stable
A porcine gammaherpesvirus has been detected at
high copy numbers in miniature swine presenting an
early form of PTLD (Huang et al., 2001). We compared the
complete gB sequence of this herpesvirus (GenBank
accession number AY044427) with the PLHV-1 gB gene
reported in this paper and found them to be identical. We
also sequenced more than 1.5 kb of the gB gene and the
entire noncoding region between ORF 11 and 17 from a
virus-positive blood sample (#1187) of another miniature
swine (#13801) suffering from PTLD as well as ORFs
40–50 from a lymph node sample (#1328) of a third
PLHV-1 positive PTLD-affected swine (#13271) (data not
shown). All sequence alignments revealed nucleotide
identities in excess of 99.9%, demonstrating that the
PTLD-associated gammaherpesvirus and PLHV-1 are
essentially indistinguishable. High sequence identity
(99.9%) was also detected in PLHV-1 sequences am-
plified from German pigs, indicating PLHV-1 as a genet-
ically stable virus.
PLHV-1 genes are transcribed in lymph nodes of
PTLD-affected pigs
We examined the transcription of a number of key
PLHV genes in the lymph nodes of an immunosup-
pressed PTLD-affected miniature swine (#13813) as well
as two untreated healthy miniature swine (#14265 and
#14268). Transcripts of PLHV-1 ORF 03, ORF E4/BALF1h,
ORF 08 (gB), ORF A5/BILF1h, ORF 29, ORF 45, ORF50,
and ORF A7/BZLF2h. were detected in the PTLD-affected
animal, but not in the healthy pigs (Fig. 3, Table 2).
As known from other herpesviruses, the ORFs 29
(terminase) and ORF 50 (rta homologue) are spliced
genes. For the detection of transcripts of these genes
in PLHV-1-infected lymph nodes, primers were used
which flanked the predicted splice sites. The sizes of
the ORF 29 (primers 989-s and 990-as) and the ORF 50
(primers 988-s and 988-as, Fig. 1b) PCR products were
as expected for spliced transcripts and verified by
sequencing (data not shown).
The first ORF analysis of the 73-kbp genome stretch of
PLHV-1 showed that ORF A6/BZLF1h was significantly
shorter (104 aa) than its positional counterparts in AIHV-1
(210 aa) and EBV (245 aa), resulting in a 487-bp gap
between the predicted ORFs A6/BZLF1h and A7/BZLF2h.
As EBV ORF BZLF1 is a spliced gene consisting of three
FIG. 3. PLHV gene expression in normal and PTLD affected tissues.
As an example, some of the RT-PCR results are shown for the genes
indicated above the left part of gel. Lanes are labeled for the template
cDNA: (PTLD)  RNA/cDNA prepared from a lymph node of a non-
treated, healthy pig; (PTLD)  RNA/cDNA prepared from a lymph
node of a PTLD-affected pig, (RT) indicates “no reverse transcriptase”
control, RNA prepared from the same PTLD-affected pig. As a positive
control, the right part of the gel shows the PCR results with genomic
DNA from a lymph node of a PTLD-affected pig as template. (M), 100 bp
ladder (Promega), (e), empty lane.
FIG. 2. Phylogenetic relatedness of PLHV-1. Phylogenetic trees were
constructed with the neighbor/joining method, using concatenated
multiple amino acid sequence alignments of conserved regions of (a)
ssDNABP (ORF06), gB (ORF 08), DPOL (ORF 09), terminase (ORF 29),
and helicase (ORF 44) and (b) gB and DPOL. The PLHV-1 amino acid
sequences were deduced from the nucleotide sequence determined in
this study. Amino acid sequences of other gammaherpesviruses were
obtained from GenBank (accession numbers in Methods). The boot-
strap values are indicated at the branches of the tree. Low bootstrap
values were found for BoHV-4, EHV-2, and MHV68, indicating uncertain
branching. These values are not included in the figure.
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exons, we performed RT-PCR analysis for PLHV-1 to
determine whether additional exons were encoded
within the 487-bp gap. Lymph node RNA from a PTLD-
affected pig (#14203) was used for cDNA preparation.
Sequence analysis of different PCR products which were
shorter than predicted from the genome sequence re-
vealed that ORF A6/BZLF1h consists of three exons (Fig.
1b). The longest spliced transcript of this ORF was de-
tected with primers 1480-s and 1478-as. The amplimer
contains the initial ATG and ends 12 bp upstream of a
stop codon which is followed by a polyadenylation sig-
nal. From these data, a coding capacity of 172 aa can be
deduced. As A6/BZLF1h analysis is part of an ongoing
project on PLHV-1 transcription, RACE analysis will be
carried out to confirm this result.
DISCUSSION
This study provides the complete sequence of a major
part of the genome of PLHV-1, the first porcine gamma-
herpesvirus to be described. The region sequenced
spans approximately 73 kbp and comprises more than
60 ORFs (Table 1). Sequence analysis of more than
10 kbp including several noncoding regions of the gam-
maherpesvirus DNA amplified from three different PTLD-
affected miniature swine and of PLHV-1 DNA amplified
from healthy German domestic pigs showed, in compar-
ison with the PLHV-1 73 kbp sequence, more than 99.9%
identity. This indicates the general genetic stability of
PLHV-1 and shows, together with the marked increase of
PLHV-1 copies in PTLD-affected miniature swine (Huang
et al., 2001), the association of PLHV-1 with PTLD.
Experimental porcine PTLD presents with symptoms
very similar to human PTLD, which has a close associ-
ation with EBV (Huang et al., 2001). Interestingly, four
PLHV-1 genes not conserved among the Gammaherpes-
virinae (ORFs E4/BALF1h, A5/BILF1h, A7/BZLF2h, and A8/
BLLF1h) might be involved in the pathological similarities
between PLHV-1-associated PTLD in pigs and EBV-as-
sociated PTLD in humans and are discussed below.
The E4/BALF1h gene of PLHV-1 encodes a v-bcl-2
homologue from the same genomic position as EHV-2
(ORF E4) and EBV (BALF1). Viral bcl-2 genes are hypoth-
esized to confer evasion from the immune system and to
promote tumorigenesis by preventing apoptosis as a
response to virus infection (Thompson, 1995). EBV
BALF1 represents, in addition to BHRF1, the second
protein of EBV with this function (Marshall et al., 1999).
E4/BALF1h, E4, and BALF1 lack a putative C terminal
transmembrane domain which is in contrast to, e.g., the
ORF16-encoded v-bcl-2 of HVS, HHV-8/KSHV, and
BoHV-4, as well as BHRF1 of EBV or human bcl-2 and
bax. Future experiments are required to determine
whether these three viral bcl-2 genes are functional. The
completion of the sequencing of PLHV will reveal
whether this virus also encodes a second v-bcl-2-like
EBV BHRF1. The putative PLHV-GCR (A5/BILF1h) and the
corresponding GCR of AIHV-1, EHV-2, and EBV (A5, E6,
and BILF1, respectively) show weak homology to the
ORF 74 gene products of KSHV and other rhadinoviruses.
The ORF74 gene product of KSHV has been found to
encode a functional homolog of human IL-8R and to
behave as an oncogene in KSHV-mediated tumors by
constitutively activating cell-signalling pathways to in-
duce transformation and angiogenesis (Arvanitakis et al.,
1997; Bais et al., 1998). We have also sequenced the
porcine IL-8R gene and compared it with the PLHV-GCR.
No greater homology was found between porcine IL-8R
and the PLHV-GCR as compared to other mammalian
GCRs (M. Goltz and B. Ehlers, paper in preparation).
These results may indicate that the GCR gene was
present in an ancestor of PLHV-1, AIHV-1, EHV-2, and EBV
at a time before the cospeciation of mammals and their
herpesviruses. Future functional studies are required to
elucidate the role of the putative PLHV-GCR in the patho-
genesis of PTLD. Because the mechanisms by which
gammaherpesviruses can induce lymphoproliferative
conditions are not precisely defined, it will be interesting
to examine the biological functions of the novel PLHV
v-bcl and GCR as this might provide further insight into
the mechanisms of proliferation as well as transforma-
tion.
The A7/BZLF2h and A8/BLLF1h. genes are likely to
affect the cell tropism of PLHV. The protein deduced from
the A7/BZLF2h ORF is related to the BZLF2 glycoprotein
of EBV which was reported to form a ternary complex
with the glycoproteins gH and gL. In this complex, BZLF2
is essential for the entry of EBV into B cells via HLA-DR
(Spriggs et al., 1996; Wang and Hutt-Fletcher, 1998). In
AIHV-1, the homologous A7 seems to be required for
AIHV-1 pathogenicity in rabbits (Handley et al., 1995).
A8/BLLF1h is the homolog of A8 of AIHV-1 (Ensser et al.,
TABLE 2
PLHV-1 Genes Transcribed in a PTLD-Affected Pig
ORF
PIG
#13813
PTLD
PIG
#14265
unaffected
PIG
#14268
unaffected
E4/BALF1 v-bcl-2 a —b —b
3 Tegument  — —
8 Glycoprotein B  — —
A5/BILF1 GCR  — —
29 Terminase  n.d. n.d.
45 IE protein  — —
50a, b IE protein  — —
A7/BZLF2 Glycoprotein c —c —c
Note. a, b, No RT controls were in all cases negative. n.d., PCR not
done.
a RT-PCR results from the lymph nodes of a PTLD pig.
b RT-PCR results from the lymph nodes of nontreated, healthy pigs.
c Results were identical with two different primer pairs, see Materials
and Methods section.
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1997) and BLLF1 (gp350/220) (Jackman et al., 1999). The
latter protein is required for the attachment of EBV to B
cells via the complement receptor molecule CD21 (Tan-
ner et al., 1987; Haan et al., 2000) and was reported to
induce apoptosis of T cells (Tanner and Alfieri, 1999).
Although a functional analysis of the respective EHV-2
and AIHV-1 ORFs has not been reported, a B cell tropism
has also been observed for EHV-2 (Drummer et al., 1996).
The tropism of AIHV-1 in its natural host, the wildebeest,
is not known. However, the closely related OvHV-2, like
AIHV-1 a causative agent of MCF in cattle, was found in
B cells of its natural host, the sheep (Baxter et al., 1997).
There are two lines of evidence which indicate that
PLHV-1 also has B cell tropism. First, oligoclonal prolif-
eration of cells of the B lineage by a factor of approxi-
mately 102 was observed in lymph nodes in immunosup-
pressed pigs suffering from PTLD and the amount of
PLHV-1 genome copies concomitantly rose by a factor of
105 (Huang et al., 2001). Second, we demonstrate in the
tissue of a PTLD-affected pig, the transcriptional activity
of two ORFs (A7/BZLF2h and A8/BLLF1h) (Table 2) which
encode proteins putatively responsible for entry into B
cells (Table 1). Taken together, these data are strongly
suggestive of PLHV-1 infecting B cells.
According to amino acid sequence comparisons (Ta-
ble 1) and phylogenetic analyses (Fig. 2), the partial
genome of PLHV-1 has a gene content and arrangement
very similar to the ruminant rhadinovirus AIHV-1. In ad-
dition, the low GC content of 37% and the strong
suppression of the CpG dinucleotide frequency is indic-
ative for a rhadinovirus (Ulrich et al., 1999). A character-
istic feature of the lymphocryptoviruses is the presence
of several genes coding for nuclear antigens (EBNA
genes), which are involved in the maintenance of EBV
latency (Masucci and Ernberg, 1994). No such homologs
were identified in PLHV-1. Taken together, these data
suggest that PLHV-1 should be classified as a rhadino-
virus. However, four ORFs of PLHV-1 (E4/BALF1h, A5/
BILF1h, A7/BZLF2h, and A8/BLLF1h) question this conclu-
sion. All four ORFs have homologs in EBV (lympho-
cryptovirus). Three of them have homologs in AIHV-1
(rhadinovirus) and one of them in EHV-2 (rhadinovirus).
No such ORFs have been identified in other completely
sequenced rhadinoviruses. A likely explanation might be
a common ancestor of PLHV-1, AIHV-1, EHV-2, and EBV,
which diverged earlier from a common ancestor of the
primate rhadinoviruses, thus separating PLHV-1 (and
AIHV-1, EHV-2) from the other rhadinoviruses and linking
them evolutionaryly closer to EBV. However, for a final
classification, the complete PLHV-1 genome sequence is
needed.
PLHV-1 DNA was abundant in peripheral blood mono-
nuclear cells and lymph nodes of pigs affected with
PTLD (Huang et al., 2001). Now we observed that imme-
diate–early (e.g., ORFs 45, 50) and late (e.g., major capsid
protein, gB, terminase) PLHV-1 genes as well as the
genes coding for a GCR and a v-bcl-2 are actively tran-
scribed in PTLD-affected pigs but were undetectable in
healthy pigs (Table 2). Presently, we do not precisely
know whether only the number of cells supporting PLHV
transcription is increased or, in addition, the transcription
per cell is increased. However, the disproportionate rise
in PLHV DNA (Huang et al., 2001) suggests the latter
possibility. In EBV-associated human PTLD, although the
majority of malignant lymphoid proliferations are thought
to be associated with latent EBV, it has been claimed that
lytic activity of EBV might also be associated with the
initiation of the disease process (Rea et al., 1994a, 1994b;
Montone et al., 1996). Taken together, these data support
the hypothesis that PLHV-1 is involved in the etiology of
PTLD.
PLHV-1, being possibly causative of porcine PTLD,
raises a concern with respect to the use of porcine cells
and tissues in xenotransplantation. Although humans
and pigs are only very distantly related species (Murphy
et al., 2001), the transmission of PLHV-1 from porcine
cells and tissues to human xenotransplant recipients
and subsequent adaptation might be possible, espe-
cially as transplant recipients are likely to be immuno-
suppressed. Furthermore, several herpesviruses have
successfully been transmitted between different species
which are sometimes only distantly related. This is ex-
emplified by pseudorabiesvirus which infects not only
pigs but also dogs and cats (Kelley and Ratcliffe, 1983;
Hagemoser et al., 1980), and OvHV-2 which is well
adapted to its natural host, the sheep, but causes MCF
with high mortality not only in cattle but also in pigs
(Loken et al., 1998 and M. Ackermann, S. Albini, and B.
Ehlers, manuscript in preparation). The close relation-
ship of PLHV-1 to AIHV-1 (Table 1, Fig. 2) and other MCF
viruses (Fig. 2b) like OvHV-2 is an indication that PLHV-1
is potentially pathogenic not only for pigs but also for
immunosuppressed transplant recipients. Therefore,
elimination of PLHV-1 may be mandatory for the use of
pigs in xenotransplantation. This requires knowledge
about how PLHV is transmitted to offspring and the
identification of the sites of latency. Completion of the
PLHV-1 sequence will reveal candidate latency-associ-
ated genes and elucidate the presence of other genes
potentially involved in the pathogenicity of PLHV-1. Fur-
thermore, comparison of the gene content and molecular
pathogenesis of PLHV-1 and EBV with respect to their
capability to induce lymphoproliferative conditions will
answer the question whether PLHV-1 in pigs may be a
suitable large animal model system for human PTLD.
MATERIALS AND METHODS
Sample collection
Blood samples were collected from commercial pig
herds and spleens from a slaughterhouse in Branden-
burg, Germany. Spleens from pigs of commercial herds
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in Spain were kindly provided by M. Domingo (Univer-
sidad de Barcelona, Spain). Lymph node samples from
experimental MGH MHV-inbred miniature swine were
collected at the Transplantation Biology Research Unit
(TBRC), Massachusetts General Hospital, Harvard Med-
ical School, Boston, MA.
Induction of PTLD
MGH MHV-inbred miniature swine were conditioned 2
days prior to allogeneic peripheral blood stem cell trans-
plantation with thymic irradiation and in vivo T cell de-
pletion and treated daily with cyclosporine beginning 1
day prior to transplantation and continuing for 30 to 60
days as described earlier (Huang et al., 2001). On the
occurrence of clinical signs of PTLD, the animals were
sacrificed and organ samples collected.
Genome walking
PLHV-1 sequence information was generated by ge-
nome walking followed by sequencing of the PCR prod-
ucts. Genome walking was carried out as described
earlier for the PLHV DNA polymerase locus (Ulrich et al.,
1999). In brief, spleen samples of a Spanish pig (#056)
PCR-positive for PLHV-1 (0.1–1 genome per cell) but
PCR-negative for PLHV-2 (Ulrich et al., 1999) as well as
two PLHV-1-negative pigs (#054, Spain and #504, Ger-
many) as negative controls were used for DNA prepara-
tion with the QIAamp Tissue kit (Qiagen, Chatsworth,
CA). Genome walking was performed by Genexpress
GmbH (Berlin, Germany) using the Universal Genome-
WalkerTM Kit (Clontech Laboratories, Palo Alto, CA)
(Siebert et al., 1995a,b). Six restriction enzymes were
used for generating batches of digested genomic DNA
which were ligated to adaptors. PLHV amplimers were
generated by nested PCR using adaptor- and PLHV-
specific primers.
Sequence determination
PCR fragments obtained by genome walking were
sequenced using BigDye terminator chemistry and ABI
377 or ABI 3100 automated sequencers (Applied Biosys-
tems, Foster City, CA). Additional overlapping PCRs were
performed for sequence completion with 100 ng of por-
cine DNA using AmpliTaq Gold (Applied Biosystems)
under the following conditions: 12 min activation at 95°C,
45 cycles with 20 s at 95°C, 30 s at primer-dependent
annealing temperature (usually 55–65°C) and 2–3 min at
72°C followed by final extension at 72°C for 15 min. PCR
products were purified from remaining primers and
dNTPs using Microspin S-300 HR or S-400 HR columns
(Amersham Biosciences) and sequenced as described
above. The sequence was determined double-stranded,
with a 7.5-fold redundancy on average. Each basepair
was determined from at least two PCR amplimers gen-
erated with different primers.
Nucleotide and protein sequence analysis
The sequence files were assembled with the AutoAs-
sembler software (Applied Biosystems). ORF prediction
and initial analysis was performed with MacVector (Ver-
sion 7.0, Oxford Molecular Group). BLAST searches were
performed at the NCBI database, and GAP program from
the GCG package (Devereux et al., 1984) was used for
calculating similarity and identity values.
ORF designation
Genome orientation and nomenclature of the PLHV-1
ORFs were adapted to the standard nomenclature of
rhadinovirus genomes and the reference virus HVS (Al-
brecht et al., 1992). The ORFs which are present in
PLHV-1 and in only a minority of gammaherpesviruses
(AIHV-1, EHV-2, and EBV) were designated as homologs
of the most similar gene, present in AIHV-1 or EHV-2 at
the same position, and the corresponding EBV gene (for
example E4/BALF1h or A5/BILF1h). The ORFs unique to
PLHV-1 having no homologs in databases were not
named in order to avoid redesignation after possible
detection of additional unique ORFs between the 5-end
of the sequence and the left terminus of the genome.
Multiple sequence alignments and phylogenetic
analysis
Multiple sequence alignments of individual proteins
were performed and protein pair distances calculated
with the clustalW module of MacVector. For phylogenetic
analysis, gaps or insertions unique to a certain species
were removed from the multiple sequence alignments
and the remaining conserved regions concatenated for
each individual protein (McGeoch et al., 2000). Finally,
the combined sequences were again concatenated to
produce a single phylogenetic tree which is based on
multiple genes (Searles et al., 1999). The tree was con-
structed with the PHYLIP program package using the
programs Protdist (Dayhoff PAM matrix) and Neighbor or,
alternatively, the program Protpars with randomized in-
put of sequences. The tree was statistically evaluated by
bootstrap analysis (1000-fold resampling), using the pro-
grams Seqboot and Consense (Felsenstein, 1985, 1993).
Nucleotide sequence accession numbers and virus
abbreviations
The accession number for the 73-kbp sequence of
PLHV-1 presented in this study is AF478169. Abbrevia-
tions and accession numbers for the sequences used in
comparisons are the following.
Complete genomes: AIHV-1 (alcelaphine herpesvirus 1)
(accession no. AF005370); BoHV-4 (bovine herpesvirus 4)
(accession no. AF318573); EBV (Epstein-Barr virus) (acces-
sion no. X00784); EHV-2 (equine herpesvirus 2) (accession
no. U20824); HHV-8 (human herpesvirus 8) (accession no.
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U75698); HVS (herpesvirus saimiri or saimiriine herpesvirus
2 [SaHV-2]) (accession no. X64346); HVA (herpesvirus ate-
les or ateline herpesvirus 3 [AtHV-3]) (accession no.
AF083424); MHV-68 (murine gammaherpesvirus 68) (ac-
cession no. U97553); RRV (rhesus monkey rhadinovirus)
(accession no. AF029302).
DPOL and gB sequences: BLHV (bovine lymphotropic
herpesvirus) (DPOL, accession no. AF327830; gB, acces-
sion no. AF327832); CprHV-2 (caprine herpesvirus 2) (gB
and DPOL, accession no. AF283477); OvHV-2 (ovine her-
pesvirus 2) (DPOL, accession no. AF327831; gB, acces-
sion no. AF327833).
Long-distance PCR
Long-distance PCRs were performed with the Expand
Long Template PCR System and the Expand High Fidelity
PCR System (Roche Diagnostics, Germany) according to
the manufacturer’s instructions. Amplimers were ob-
tained by nested PCRs. For the second round reaction,
1 l of the first PCR reaction was used as template. The
following primers were used.
fragment A, first round: 1461-s 5-CATACCTTGTGCG-
AGTGAGTGGAC-3  1461-as 5-ATAGTGACCTGT-
TAGCGGCGATTC-3, second round: 1462-s 5-CACTA-
ACTCCTATTACCCCACATG-3  1462-as 5-TGAGCTATA-
CAAGCTACCACAGAA-3, fragment B, first round: 1463-s
5-TCATTCTCAAAGAACAACCTTGCC-3  1463-as 5-TTTG-
AGCGGTAGACTCTGGTAGCC-3, second round: 1464-s 5-
AACCTAATTAAACAGAATTCATCGCA-3  1464-as 5-AAAT-
GTCCACAAAGACTCCGTCGT-3, fragment C, first round:
1465-s 5-CAGGTGGAACCCTTACCAGCAGAT-3  1465-as
5-AGATCCAGATCATGCTCCTTTGCC-3, second round:
1466-s 5-ATTATGTCTGATACTCACTGTTGCTA-3  1466-as
5-TCCAATGTCTTGTGATAATTCCTA-3, fragment D, first
round: 1467-s 5-GAGGTCAATGGTCCAACTAAGG-3 
1467-as 5-AGAACAAATACGAGCGATAAAA-3, second
round: 1468-s 5-GTCTAAGAGCATCTTCGCTACAC-3 
1468-as 5-CAACTTCCATGATACGGTCAACT-3, fragment E,
first round: 696-s 5-GAACACTAACCATTTCCTACATT-3 
837-as 5-ATCGCTTATCTGTATCACTCTATCGT-3, second
round: 698-s 5-TACCTTCCCCAACGAGCTTTACA-3 
794-as 5-AGCTTAGTTACGCCTAACACTTGC-3, fragment
F, first round: 803-s 5-AGATCATGAACGATCATTACAA-3 
936-as 5-ATCCATATTGATGTTGGATTG-3, second
round: 776-s 5-GCCGAGGGTACTTACGCCAACATT-3 
964-as 5-TGTGACATTTTAGATGTCAGTCCC-3; fragment
G, first round: 881-s 5-CTCATATCTAGTCCAGTCGAA-
CAA-3  1218-as 5-GTAGTCTGGTCCTGTCCGTTTA-3,
second round: 883-s 5-AACCGTCGTAGCTTCTCA-
AAATC-3  1181-as 5-CCTCGTGTCTGGGGTAACTAT-3.
Preparation of cDNA and PCR
Random primed cDNA was prepared from 1.2 g of
total cellular RNA from lymph node tissue, using the
SuperScript First-Strand Synthesis System (Gibco BRL,
USA) according to the manufacturer’s instructions. Ran-
dom hexamer oligonucleotides were used to prime the
reverse transcriptase to the RNA. PCR was performed
with HotStarTaq (Qiagen) according to the manufactur-
er’s instructions. The following primers were used.
ORF E4/BALF1: sense: 5-GTTAACTTGGCTGGTAAAGC-
AA-3, antisense: 5-CTTGTATTCTAACCATCCACGG-3;
ORF 03/tegument: sense: 5-TTCCCAACTTCAAGATTTACA-
C-3, antisense: 5-GTATTTGCTTGGATTGCTAAAA-3; ORF
08/gB: sense: 5-CACAAGCGTCATGAGCATG-3, antisense:
5-TAACGGTCTTCTCGTCCCTG-3; ORF A5/BILF1: sense:
5-CAATGGAATTGTCAACTCCTCT-3, antisense: 5-TA-
GCAACAGTGAGTATCAGACATAAT-3;ORF 45/IE: sense: 5-
TTGTGCTTTAATTTTCTTGTTACTG-3, antisense: 5-T-
CGGGTCCTCATGATATTCTTC-3; ORF 50/IE: sense: 5-
CTGACTGCAATTCAATCCAACAT-3, antisense: 5-
CAAGCATTCTTCCCTGACCTACA-3; ORF A7, no1:
sense: 5-TTCCTCATACAGATGATGTAGGGC-3, anti-
sense: 5-CACTGTGAATCTGGGCTTCTTTTA-3; ORF
A7, no2: sense: 5-TTTTGTATTTCCTCATACAGATG-3,
antisense: 5-GCATAAAACCAGTAACATTTAGA-3.
The reactions were denatured for 15 min at 95°C,
followed by 36 cycles of 10 s at 95°C, 30 s at 55°C, and
30 s at 72°C. The thermal cycling was concluded with an
incubation at 72°C for 5 min.
For the detection of spliced transcripts of ORF 29, a
nested PCR was performed. Primers 990-s (5-
CAACGGCCACCAACAGATCATCTGA-3) and 989-as
(5-TTAATTCCAAGAAGACATGGGA-3) were used for
first-round PCR, primers 989-s (5-TGGCAACTTCACT-
CACTATCTG-3) and 990-as (5-TAGGTTATGTTGCA-
CATCAGAAG-3) for the second-round PCR. For detec-
tion of spliced transcripts of ORF 50 primers 988-s
(5-CTGACTGCAATTCAATCCAACAT-3) and 988-as
(5-CAAGCATTCTTCCCTGACCTACA-3) were used.
PCR reactions were performed with 1 l of 1:2 diluted
oligo-dT-cDNA using AmpliTaq Gold as described
above (Sequence determination) with an annealing
temperature of 57 or 58°C and an elongation time of
3 min. For detection of spliced transcripts of ORF A6,
cDNA was prepared from total cellular RNA from
lymph node tissue, using the RNeasy Mini Kit (Qiagen,
Germany). The longest spliced transcript was detected
with primers 1480-s (5-TAAAAGACTAACAAAACATG-
CACA-3) and 1478-as (5-AAATTGAGTATCTGGAAA-
CACTGA-3). PCR reactions were performed with 1 l of
1:10 diluted oligo-dT-cDNA using AmpliTaq Gold as de-
scribed above (Sequence determination) with an annealing
temperature of 57°C and an elongation time of 2 min.
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